Article
Heron scores FDA go-ahead for Aponvie, an IV alternative to pills for postoperative nausea
Rating:
0.0
Views:
53
Likes:
1
Library:
1
Heron Therapeutics has two drugs on the market to prevent the nausea and vomiting associated with chemotherapy. Now, it has one to prevent the sickness that often comes after surgery. | On Friday, the FDA approved Aponvie, which becomes the first intravenous P/neurokinin-1 (NK) receptor antagonist available for postoperative nausea and vomiting (PONV) in adults. Delivered in a single 30-second IV injection, Aponvie is the same drug as Merck's Emend, which is now widely available as a generic.
Rating:
0.0
Views:
53
Likes:
1
Library:
1
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value